To evaluate whether this also occur in breast tumors in vivo, TMA slides from the same tumor blocks were immunohistochemically stained with BRCA1-IRIS, AKT1, AKT2, p-AKT, survivin and BRCA1/p220 specific antibodies. Here, BIRC5 is linked to breast neoplasm.